Claudia Schollkopf

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration.

Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration.

Journal: HemaSphere

Published: May 13, 2026

Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method.

Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method.

Journal: Human mutation

Published: December 02, 2025

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

Journal: Molecular oncology

Published: November 20, 2025

Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline-containing chemotherapy: A population-based matched cohort study.

Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline-containing chemotherapy: A population-based matched cohort study.

Journal: British journal of haematology

Published: April 29, 2025

Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population-based cohort study.

Reproductive patterns and birth rates in acute leukaemia survivors: A Danish population-based cohort study.

Journal: British journal of haematology

Published: March 14, 2025

Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.

Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.

Journal: Blood cancer journal

Published: February 17, 2025

Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort study.

Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort study.

Journal: The Lancet regional health. Europe

Published: October 16, 2024

AXL in myeloid malignancies - an elusive target?

AXL in myeloid malignancies - an elusive target?

Journal: Biomarker research

Published: September 25, 2024

Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations.

Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations.

Journal: Haematologica

Published: April 04, 2024

Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study.

Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study.

Journal: Clinical epidemiology

Published: October 11, 2023

Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy.

Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy.

Journal: European journal of haematology

Published: June 06, 2023

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.

Journal: Clinical epigenetics

Published: December 21, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026